What companies are BIIB's competitors?

Biogen Inc. (BIIB)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does BIIB compare to its peers?

The peer comparison table on this page shows Biogen Inc. (BIIB) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does BIIB operate in?

Biogen Inc. (BIIB) operates in the Drug Manufacturers - General industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

BIIB

Biogen Inc.

NASDAQ·Drug Manufacturers, General · Healthcare

$200.62$2.88+1.46%

After hours·$199.00−0.81%

Market cap$29.62B·Market closed·Jul 23 8:00 PM UTC

Frequently Asked Questions About BIIB

What companies are BIIB's competitors?: Biogen Inc. (BIIB)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does BIIB compare to its peers?: The peer comparison table on this page shows Biogen Inc. (BIIB) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does BIIB operate in?: Biogen Inc. (BIIB) operates in the Drug Manufacturers - General industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

BIIB

Biogen Inc.

NASDAQ·Drug Manufacturers, General · Healthcare

$200.62$2.88+1.46%

After hours·$199.00−0.81%

Market cap$29.62B·Market closed·Jul 23 8:00 PM UTC

Peers


TEVA	Teva Pharmaceutical Industries Limited	$31.18	$36.3B
DXCM	DexCom, Inc.	$70.48	$27.2B
DGX	Quest Diagnostics Incorporated	$227.90	$25.2B
WAT	Waters Corporation	$382.41	$24.9B
LH	Labcorp Holdings Inc.	$291.02	$23.9B
INCY	Incyte Corporation	$116.69	$23.3B
UTHR	United Therapeutics Corporation	$529.53	$22.5B
STE	STERIS plc	$210.64	$20.5B
GMAB	Genmab A/S	$29.17	$17.9B
PODD	Insulet Corp.	$158.38	$11.0B

Frequently Asked Questions About BIIB

What companies are BIIB's competitors?: Biogen Inc. (BIIB)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does BIIB compare to its peers?: The peer comparison table on this page shows Biogen Inc. (BIIB) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does BIIB operate in?: Biogen Inc. (BIIB) operates in the Drug Manufacturers - General industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.